GlucoTrack (GCTK) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
12 Mar, 2026Opening remarks and agenda
The meeting was called to order at 11 A.M. Eastern Time and presided over by the CEO, with the CFO and outside counsel present.
The agenda was adopted, and participation was limited to stockholders of record and their proxies.
Specific resolutions to be voted on
Approval of the full issuance of shares to Sixth Borough Capital Fund, LP under a purchase agreement dated September 11, 2025, potentially exceeding 20% of outstanding stock.
Approval of the full issuance of shares upon exercise of 2,067,182 common warrants issued in a private placement that closed on December 31, 2025.
Ratification of the selection of CBIZ CPAs P.C. as independent registered public accountants for the fiscal year ending December 31, 2025.
Corporate governance
The Inspector of Elections was appointed and sworn in to oversee and tabulate voting.
A quorum was confirmed with 44.1% of eligible votes present or represented by proxy.
No other proposals were received in accordance with the bylaws.
Latest events from GlucoTrack
- Votes sought for major stock issuances, auditor ratification, and potential meeting adjournment.GCTK
Proxy Filing9 Feb 2026 - Major stock issuances and auditor ratification proposed, with significant dilution possible.GCTK
Proxy Filing29 Jan 2026 - Registers 3.2M shares for resale—354% of current shares—amid financial and regulatory risks.GCTK
Registration Filing13 Jan 2026 - Innovative implantable CGM in development, with $30M shelf registration and notable financial risks.GCTK
Registration Filing16 Dec 2025 - Implantable CGM developer advances to human trials amid financial and Nasdaq listing risks.GCTK
Registration Filing16 Dec 2025 - Shareholders will vote on warrant share issuance, a reverse split, and increasing authorized shares.GCTK
Proxy Filing2 Dec 2025 - Key votes include director elections, a reverse stock split, and an expanded equity plan.GCTK
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, reverse split, auditor, and equity plan amendment.GCTK
Proxy Filing2 Dec 2025 - Approval sought for major share issuance tied to $4M Note and Warrants, impacting control and financing.GCTK
Proxy Filing2 Dec 2025